Skip to content

Is there a generic version of Kybella?

4 min read

While the generic name for Kybella is deoxycholic acid, no FDA-approved generic version of Kybella is currently available on the market. Instead, some clinics offer compounded deoxycholic acid as an alternative treatment for submental fat, raising important considerations regarding safety, efficacy, and cost.

Quick Summary

Kybella's active ingredient is deoxycholic acid, but an FDA-approved generic drug is unavailable. Compounded deoxycholic acid is a more affordable, non-FDA-regulated alternative for submental fat reduction.

Key Points

  • Generic Name, Not Generic Drug: The generic name of Kybella is deoxycholic acid, but there is no FDA-approved generic drug version available.

  • Compounded Deoxycholic Acid: Compounded versions of deoxycholic acid are offered by some clinics as a cheaper alternative to Kybella but are not FDA-regulated.

  • FDA Approval and Safety: Kybella is FDA-approved based on extensive clinical trials, while compounded versions lack this regulatory oversight and clinical evidence, posing potential safety risks.

  • Cost vs. Quality: The lower price of compounded deoxycholic acid reflects the lack of regulatory safeguards and clinical trial data, unlike the higher-priced, quality-assured brand-name Kybella.

  • Non-Injectable Alternatives: Non-invasive options like CoolSculpting and more permanent surgical solutions like liposuction or a neck lift are also available for submental fat reduction.

  • Consultation is Key: Discussing all options with a qualified healthcare professional is crucial to choosing the safest and most effective treatment for your needs.

In This Article

The Generic Name vs. a Generic Drug: Kybella's Case

When discussing Kybella, it is crucial to understand the difference between a drug's generic name and a generic drug product. The generic name of Kybella is deoxycholic acid. This is the active ingredient, a naturally occurring molecule in the body that helps break down and absorb dietary fat. When synthetically produced and formulated into an injectable, it becomes the foundation of the Kybella treatment. A generic drug, on the other hand, is a copy of a brand-name drug that is manufactured and sold after the original drug's patent expires. It must be proven to be bioequivalent to the brand-name version and undergo FDA approval. Kybella was first approved by the FDA in 2015, and its patents are expected to expire around 2028, meaning a true, FDA-approved generic is not yet on the market.

Kybella vs. Compounded Deoxycholic Acid

Because of the high cost of brand-name Kybella, some providers offer compounded versions of deoxycholic acid produced by compounding pharmacies. These are often colloquially referred to as "generic Kybella," but this is a misnomer, as they are not FDA-approved generic drugs.

Regulation and Safety

Kybella is a brand-name product manufactured by AbbVie (formerly Allergan) and has undergone rigorous clinical trials to earn its FDA approval for the treatment of submental fullness. This approval ensures its safety, efficacy, and consistent quality when used as indicated. Conversely, compounded deoxycholic acid is not FDA-approved. While the active ingredient is chemically identical, the compounded product has not been subjected to the same level of testing for safety and effectiveness. There are also risks of counterfeit or unsafe products when using non-FDA-approved injectables, as cautioned by the FDA.

Cost and Accessibility

Compounded deoxycholic acid is significantly more affordable than brand-name Kybella. This substantial cost difference makes treatment more accessible for patients concerned with the price point. For instance, the cost of several vials of compounded deoxycholic acid might be equivalent to the price of a single vial of the brand-name version. Kybella typically ranges from $600 to $1,800 per session, with multiple sessions required for optimal results, whereas compounded options can be considerably cheaper.

Efficacy and Results

Clinical trials have confirmed Kybella's effectiveness in destroying submental fat cells, with results being permanent as long as the patient maintains a stable weight. The clinical evidence supporting compounded deoxycholic acid, however, is limited. While practitioners may report comparable results, the lack of extensive data means the long-term safety and consistency of the compounded version are less certain. Some providers suggest the affordability of compounded deoxycholic acid allows for the use of larger doses, which they claim can lead to better outcomes.

Comparison Table: Kybella vs. Compounded Deoxycholic Acid

Feature Kybella (Brand Name) Compounded Deoxycholic Acid (Non-FDA Approved)
Active Ingredient Deoxycholic Acid Deoxycholic Acid
FDA Status FDA-Approved for submental fat reduction Not FDA-Approved. Made by compounding pharmacies
Clinical Evidence Extensive clinical trial data confirming safety and efficacy Limited clinical trial data
Cost More expensive, typically thousands of dollars for a full treatment Significantly less expensive
Consistency & Quality Manufactured under strict regulations; consistent potency and sterility Quality and consistency can vary among compounding pharmacies
Safety Profile Well-established; known and documented side effects Less established; greater potential for unknown side effects

Alternatives to Kybella for Submental Fat Reduction

For individuals seeking to reduce submental fat, several alternatives are available, each with its own benefits and considerations:

  • CoolSculpting (Cryolipolysis): A non-invasive procedure that freezes and destroys fat cells using controlled cooling technology. The specialized applicator, CoolMini, is designed for the area under the chin. It involves no needles or injections and has minimal downtime.
  • Micro Liposuction: A minimally invasive surgical procedure that removes fat through tiny incisions using a small cannula. It offers immediate and often more dramatic results compared to injectable treatments and typically requires only one session.
  • Radiofrequency Treatments: Use heat energy to both reduce fat and tighten the skin. These are non-surgical options that can improve skin laxity, which Kybella does not address.
  • Neck Lift Surgery: For those with more significant excess fat and loose skin, a neck lift is a comprehensive surgical solution. It provides the most dramatic and long-lasting results but requires a longer recovery period.

Conclusion: Making an Informed Decision

Ultimately, the question of "Is there a generic version of Kybella?" reveals a crucial distinction in aesthetic medicine. While no FDA-approved generic Kybella exists, the availability of compounded deoxycholic acid offers a cheaper alternative. However, this lower cost comes with significant trade-offs in terms of regulation, safety, and clinical backing. For patients, the choice between FDA-approved Kybella and compounded options hinges on their priorities regarding safety assurance, cost, and risk tolerance. Consulting with an experienced, qualified healthcare provider who can explain the pros and cons of each option is the most important step before deciding on treatment for submental fat. It is essential to ensure that any product being injected is safe and appropriate for your specific needs.

Learn more about FDA-approved drugs at Drugs.com.

Frequently Asked Questions

Kybella is an FDA-approved, brand-name injectable drug for submental fat reduction. Compounded deoxycholic acid is a product made by compounding pharmacies that is not subject to FDA approval or oversight, meaning its safety and efficacy are not guaranteed.

Compounded deoxycholic acid is cheaper because it does not have the research, development, and extensive clinical trials required for FDA approval that brand-name Kybella does. The manufacturing and regulatory costs are significantly lower.

The safety of compounded deoxycholic acid is not established in the same way as FDA-approved Kybella. Without regulatory oversight, there is a risk of variations in product potency, sterility, and overall safety. The FDA advises caution with non-approved injectables.

Authentic Kybella vials are manufactured by AbbVie and feature a unique hologram on the label. If this hologram is missing, the product may be counterfeit. Always confirm your provider is using a genuine, FDA-approved product.

Yes, other non-surgical options exist, such as CoolSculpting (cryolipolysis) and radiofrequency treatments. These procedures use different methods to reduce fat and can also help with skin tightening.

While some practitioners may use compounded deoxycholic acid for off-label areas, the safety and effectiveness for areas outside the submental region have not been established. Kybella is only FDA-approved for the submental area, and using any injectable off-label carries additional risks.

A true, FDA-approved generic version of Kybella is not expected to be available until the original patents expire, which is anticipated to be around 2028.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.